Request Deal Involvement

GL Capital to acquire SciClone Pharmaceuticals for HKD8.79 bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Opus Capital

financial advisors

Opus Capital

Clifford Chance

legal advisors

Clifford Chance

Sullivan & Cromwell

legal advisors

Sullivan & Cromwell

Kirkland & Ellis

legal advisors

Kirkland & Ellis

Slaughter & May

legal advisors to financial advisors

Slaughter & May

China International Capital

financial advisors

China International Capital

or

Principals

SCICLONE PHARMACEUTICALS INC

target

SCICLONE PHARMACEUTICALS INC

GL CAPITAL GROUP

bidder

GL CAPITAL GROUP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - GL Capital to acquire SciClone Pharmaceuticals for HKD8.79 bn.